Skip to main content
SpringerLink
Log in

A response to “Effect of CYP2D6 pharmacogenetic phenotype and phenoconversion on serum concentrations of antidepressants and antipsychotics: a retrospective cohort study”

  • Letter to the Editor
  • Published:
International Journal of Clinical Pharmacy Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Scherf-Clavel M, Frantz A, Eckert A, et al. Effect of CYP2D6 pharmacogenetic phenotype and phenoconversion on serum concentrations of antidepressants and antipsychotics: a retrospective cohort study. Int J Clin Pharm. 2023. https://doi.org/10.1007/s11096-023-01588-8.

    Article  PubMed  Google Scholar 

  2. Bakken GV, Molden E, Knutsen K, et al. Metabolism of the active metabolite of quetiapine, N-desalkylquetiapine in vitro. Drug Metab Dispos. 2012;40(9):1778–84. https://doi.org/10.1124/dmd.112.045237.

    Article  CAS  PubMed  Google Scholar 

  3. Hiemke C, Bergemann N, Clement HW, et al. Consensus guidelines for therapeutic drug monitoring in neuropsychopharmacology: update 2017. Pharmacopsychiatry. 2018;51(1–02):9–62. https://doi.org/10.1055/s-0043-116492.

    Article  CAS  PubMed  Google Scholar 

  4. Milosavljevic F, Bukvic N, Pavlovic Z, et al. Association of CYP2C19 and CYP2D6 poor and intermediate metabolizer status with antidepressant and antipsychotic exposure: A systematic review and meta-analysis. JAMA Psychiatry. 2021;78(3):270–80. https://doi.org/10.1001/JAMA.2020.3643.

    Article  PubMed  Google Scholar 

  5. Stäuble CK, Lampert ML, Mikoteit T, et al. Severe adverse drug reactions to quetiapine in two patients carrying CYP2D6*4 variants: a case report. Int J Mol Sci. 2021;22(12):6480. https://doi.org/10.3390/ijms22126480.

    Article  PubMed  PubMed Central  Google Scholar 

  6. Beunk L, Nijenhuis M, Soree B, et al. Dutch pharmacogenetics working group (DPWG) guideline for the gene-drug interaction between CYP2D6, CYP3A4 and CYP1A2 and antipsychotics. Eur J Hum Genet. 2023. https://doi.org/10.1038/s41431-023-01347-3.

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

None.

Funding

The authors have not disclosed any funding.

Author information

Authors and Affiliations

  1. Department of Pharmacy, Suzhou Guangji Hospital, The Affiliated Guangji Hospital of Soochow University, Suzhou, China

    Xiang Shang

Authors
  1. Xiang Shang
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Xiang Shang.

Ethics declarations

Conflicts of interest

The author has no relevant financial or non financial interests to disclose.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Shang, X. A response to “Effect of CYP2D6 pharmacogenetic phenotype and phenoconversion on serum concentrations of antidepressants and antipsychotics: a retrospective cohort study”. Int J Clin Pharm 45, 1307–1308 (2023). https://doi.org/10.1007/s11096-023-01613-w

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11096-023-01613-w

Search

Navigation